These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32166940)

  • 21. COVID-19: Thinking about further mental and neurological disorders.
    Monteiro-Junior RS
    Med Hypotheses; 2020 Oct; 143():109894. PubMed ID: 32492561
    [No Abstract]   [Full Text] [Related]  

  • 22. Taste and Smell Dysfunction in COVID-19 Patients.
    Abalo-Lojo JM; Pouso-Diz JM; Gonzalez F
    Ann Otol Rhinol Laryngol; 2020 Oct; 129(10):1041-1042. PubMed ID: 32468830
    [No Abstract]   [Full Text] [Related]  

  • 23. SARS-CoV-2 perturbs the renin-angiotensin system and energy metabolism.
    Mori J; Oudit GY; Lopaschuk GD
    Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E43-E47. PubMed ID: 32469255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections.
    Speth RC
    Drug Dev Res; 2020 Sep; 81(6):643-646. PubMed ID: 32304146
    [No Abstract]   [Full Text] [Related]  

  • 25. Why are women better protected from COVID-19: Clues for men? Sex and COVID-19.
    Elgendy IY; Pepine CJ
    Int J Cardiol; 2020 Sep; 315():105-106. PubMed ID: 32418736
    [No Abstract]   [Full Text] [Related]  

  • 26. Tocilizumab in COVID-19: Beware the risk of intestinal perforation.
    Vikse J; Henry BM
    Int J Antimicrob Agents; 2020 Jul; 56(1):106009. PubMed ID: 32389721
    [No Abstract]   [Full Text] [Related]  

  • 27. Angiotensin Converting Enzyme 2 May Mediate Disease Severity In COVID-19.
    Gue YX; Kanji R; Markides V; Gorog DA
    Am J Cardiol; 2020 Sep; 130():161-162. PubMed ID: 32636018
    [No Abstract]   [Full Text] [Related]  

  • 28. Relationship Between ACE2 and Other Components of the Renin-Angiotensin System.
    Cohen JB; Hanff TC; Bress AP; South AM
    Curr Hypertens Rep; 2020 Jun; 22(7):44. PubMed ID: 32591908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronavirus disease 2019 and the cardiovascular system: Impacts and implications.
    Gupta MD; Girish MP; Yadav G; Shankar A; Yadav R
    Indian Heart J; 2020; 72(1):1-6. PubMed ID: 32423554
    [No Abstract]   [Full Text] [Related]  

  • 30. COVID-19 and the kidney.
    Hassanein M; Radhakrishnan Y; Sedor J; Vachharajani T; Vachharajani VT; Augustine J; Demirjian S; Thomas G
    Cleve Clin J Med; 2020 Oct; 87(10):619-631. PubMed ID: 33004323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis.
    Delpino MV; Quarleri J
    Front Cell Infect Microbiol; 2020; 10():340. PubMed ID: 32596170
    [No Abstract]   [Full Text] [Related]  

  • 32. Is COVID-19 more severe in older men?
    Liang X
    Postgrad Med J; 2020 Jul; 96(1137):426. PubMed ID: 32404490
    [No Abstract]   [Full Text] [Related]  

  • 33. Off-target ACE2 ligands: Possible therapeutic option for CoVid-19?
    Brogi S; Calderone V
    Br J Clin Pharmacol; 2020 Jun; 86(6):1178-1179. PubMed ID: 32359080
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiovascular molecular mechanisms of disease with COVID-19.
    Foo R; Wang Y; Zimmermann WH; Backs J; Wang DW
    J Mol Cell Cardiol; 2020 Apr; 141():107. PubMed ID: 32289321
    [No Abstract]   [Full Text] [Related]  

  • 35. Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19.
    Wysocki J; Lores E; Ye M; Soler MJ; Batlle D
    J Am Soc Nephrol; 2020 Sep; 31(9):1941-1943. PubMed ID: 32669323
    [No Abstract]   [Full Text] [Related]  

  • 36. Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications.
    Murray E; Tomaszewski M; Guzik TJ
    Cardiovasc Res; 2020 Jun; 116(7):e87-e89. PubMed ID: 32301968
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of SARS-CoV-2 and its functional receptor ACE2 on the cardiovascular system.
    Li M; Chen S; Xiang X; Wang Q; Liu X
    Herz; 2020 Nov; 45(7):659-662. PubMed ID: 33025029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proposed mechanism for increased COVID-19 mortality in patients with decompensated cirrhosis.
    Grace JA; Casey S; Burrell LM; Angus PW
    Hepatol Int; 2020 Sep; 14(5):884-885. PubMed ID: 32886332
    [No Abstract]   [Full Text] [Related]  

  • 39. Androgen-driven COVID-19 infection - is testosterone an enemy or a friend?
    Grubić Kezele T
    Horm Mol Biol Clin Investig; 2020 Jun; 41(2):. PubMed ID: 32598310
    [No Abstract]   [Full Text] [Related]  

  • 40. Incidence, Pathophysiology, and Impact of Coronavirus Disease 2019 (COVID-19) on Acute Ischemic Stroke.
    Majmundar N; Ducruet A; Prakash T; Nanda A; Khandelwal P
    World Neurosurg; 2020 Oct; 142():523-525. PubMed ID: 32987584
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.